LAUSR

COVID-19 has brought into sharp focus the failure of not preventing and preparing for pandemics. As the world reels from the tragedy and economic fallout of COVID-19, there are vital lessons to learn and apply in the fight against drug resistance. The unchecked growth of drug-resistant infections is a silent pandemic with long-term implications for global public health and the global economy. Now more than ever, governments have the opportunity to make robust and comprehensive investments into the way they prepare and respond to antibiotic resistance. This could cascade into lasting and long-term benefits for people and countries.